BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21358176)

  • 1. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.
    Capurso G; Bettini R; Rinzivillo M; Boninsegna L; Delle Fave G; Falconi M
    Neuroendocrinology; 2011; 93(4):223-9. PubMed ID: 21358176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
    Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
    Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
    Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
    Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.
    Capurso G; Rinzivillo M; Bettini R; Boninsegna L; Delle Fave G; Falconi M
    Br J Surg; 2012 Nov; 99(11):1480-6. PubMed ID: 22972490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended surgery for advanced pancreatic endocrine tumours.
    Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
    Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of Liver Resection Versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases.
    Yuan CH; Wang J; Xiu DR; Tao M; Ma ZL; Jiang B; Li ZF; Li L; Wang L; Wang H; Zhang TL
    Ann Surg Oncol; 2016 Jan; 23(1):244-9. PubMed ID: 26111625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
    Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
    JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: surgical treatment and outcomes.
    Cusati D; Zhang L; Harmsen WS; Hu A; Farnell MB; Nagorney DM; Donohue JH; Que FG; Reid-Lombardo KM; Kendrick ML
    J Am Coll Surg; 2012 Jul; 215(1):117-24; discussion 124-5. PubMed ID: 22726741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases.
    Guo J; Zhang Q; Bi X; Zhou J; Li Z; Huang Z; Zhang Y; Li M; Chen X; Hu X; Yihebali C; Liang J; Liu J; Zhao J; Cai J; Zhao H
    Oncotarget; 2017 Mar; 8(10):17396-17405. PubMed ID: 28030811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of non-functioning pancreatic neuroendocrine tumours based on three clinical scenarios.
    Busquets J; Ramírez-Maldonado E; Serrano T; Peláez N; Secanella L; Ruiz-Osuna S; Ramos E; Lladó L; Fabregat J
    Cir Esp; 2016 Dec; 94(10):578-587. PubMed ID: 27863693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery in malignant pancreatic neuroendocrine tumors.
    Nguyen SQ; Angel LP; Divino CM; Schluender S; Warner RR
    J Surg Oncol; 2007 Oct; 96(5):397-403. PubMed ID: 17469119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
    Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
    Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
    Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
    Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
    Cloyd JM; Poultsides GA
    World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis.
    Zhou B; Zhan C; Ding Y; Yan S; Zheng S
    Onco Targets Ther; 2018; 11():975-982. PubMed ID: 29503572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
    Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis.
    Almond LM; Hodson J; Ford SJ; Gourevitch D; Roberts KJ; Shah T; Isaac J; Desai A
    Eur J Surg Oncol; 2017 Oct; 43(10):1808-1815. PubMed ID: 28583792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.